Biological responses in stented arteries

Cardiovascular Research

Volumn 99, Issue 2, 2013, Pages 353-363

  Chaabane, Chiraz ^a   Otsuka, Fumiyuki ^b   Virmani, Renu ^b   Bochaton Piallat, Marie Luce ^a  

^a UNIVERSITY OF GENEVA   (Switzerland)

^b CVPATH INSTITUTE   (United States)

Author keywords

Endothelial cells; Extracellular matrix; Restenosis; S100A4; Smooth muscle cells

Indexed keywords

CD14 ANTIGEN; CD45 ANTIGEN; PACLITAXEL; RAPAMYCIN; TRANSFORMING GROWTH FACTOR BETA;

ARTERIOVENOUS SHUNT; BLOOD CLOTTING; BLOOD VESSEL WALL; CARDIOLOGIST; CELL MIGRATION; CELL PROLIFERATION; DRUG ELUTING STENT; ENDOTHELIUM INJURY; GENE EXPRESSION; HUMAN; IN-STENT RESTENOSIS; INFLAMMATION; INTIMA; NEUTROPHIL CHEMOTAXIS; NONHUMAN; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; PHENOTYPE; PRIORITY JOURNAL; PROSPECTIVE STUDY; REVIEW; SMOOTH MUSCLE FIBER; STENT;

ENDOTHELIAL CELLS; EXTRACELLULAR MATRIX; RESTENOSIS; S100A4; SMOOTH MUSCLE CELLS;

ANIMALS; ARTERIES; BIOMECHANICAL PHENOMENA; CARDIOVASCULAR AGENTS; CELL MOVEMENT; CELL PROLIFERATION; CONSTRICTION, PATHOLOGIC; ENDOTHELIAL CELLS; ENDOVASCULAR PROCEDURES; HEMODYNAMICS; HUMANS; MECHANOTRANSDUCTION, CELLULAR; MUSCLE, SMOOTH, VASCULAR; MYOCYTES, SMOOTH MUSCLE; NEOINTIMA; PHENOTYPE; REGIONAL BLOOD FLOW; STENTS; STRESS, MECHANICAL; VASCULAR SYSTEM INJURIES; WOUND HEALING;

EID: 84879894915     PISSN: 00086363     EISSN: 17553245     Source Type: Journal    
DOI: 10.1093/cvr/cvt115     Document Type: Review

References (84)

1. Mitra AK, Agrawal DK. In stent restenosis: Bane of the stent era. J Clin Pathol 2006;59: 232-239 (Pubitemid 43344881)
2. Otsuka F, FinnAV, Yazdani SK, Nakano M, Kolodgie FD, Virmani R. The importance of the endothelium in atherothrombosis and coronary stenting. Nat Rev Cardiol 2012;9: 439-453
3. FinnAV, NakazawaG, Joner M, Kolodgie FD, Mont EK, GoldHKet al. Vascular responses to drug eluting stents: Importance of delayed healing. Arterioscler Thromb Vasc Biol 2007; 27:1500-1510 (Pubitemid 46986103)
4. Virmani R, Kolodgie FD, Farb A, Lafont A. Drug eluting stents: Are human and animal studies comparable?. Heart 2003;89:133-138 (Pubitemid 36115090)
5. NakazawaG, Otsuka F, Nakano M, Vorpahl M, Yazdani SK, Ladich E et al. The pathology of neoatherosclerosis in human coronary implants bare-metal and drug-eluting stents. J Am Coll Cardiol 2011;57:1314-1322
6. Grewe PH, Deneke T, Machraoui A, Barmeyer J, Muller KM. Acute and chronic tissue response to coronary stent implantation: Pathologic findings in human specimen. J Am Coll Cardiol 2000;35:157-163 (Pubitemid 30061274)
7. Inoue T, Croce K, Morooka T, Sakuma M, Node K, Simon DI. Vascular inflammation and repair: Implications for re-endothelialization, restenosis, and stent thrombosis. JACC Cardiovasc Intervent 2011;4:1057-1066
8. Welt FG, Tso C, Edelman ER, Kjelsberg MA, Paolini JF, Seifert P et al. Leukocyte recruitment and expression of chemokines following different forms of vascular injury. VascMed 2003;8:1-7 (Pubitemid 36781066)
9. Kipshidze N, Dangas G, Tsapenko M, Moses J, Leon MB, KutrykMet al. Role of the endothelium in modulating neointimal formation: Vasculoprotective approaches to attenuate restenosis after percutaneous coronary interventions. J Am Coll Cardiol 2004;44: 733-739 (Pubitemid 39099565)
10. Padfield GJ, Newby DE, Mills NL. Understanding the role of endothelial progenitor cells in percutaneous coronary intervention. J Am Coll Cardiol 2010;55:1553-1565
11. Burke AP, Kolodgie FD, Farb A,Weber D, Virmani R. Morphological predictors of arterial remodeling in coronary atherosclerosis. Circulation 2002;105:297-303 (Pubitemid 34106176)
12. Welt FG, Edelman ER, Simon DI, Rogers C. Neutrophil, not macrophage, infiltration precedes neointimal thickening in balloon-injured arteries. Arterioscler Thromb Vasc Biol 2000; 20:2553-2558
13. Ross R. Atherosclerosis: An inflammatory disease. N Engl J Med 1999;340:115-126
14. Campbell JH, Campbell GR. Smooth muscle phenotypic modulation-A personal experience. Arterioscler Thromb Vasc Biol 2012;32:1784-1789
15. Wight TN, Potter-Perigo S. The extracellular matrix: An active or passive player in fibrosis? Am J Physiol Gastrointest Liver Physiol 2011;301:G950-G955
16. Charron T, Nili N, Strauss BH. The cell cycle: A critical therapeutic target to prevent vascular proliferative disease. Can J Cardiol 2006;22(Suppl. B):41B-55B. (Pubitemid 44963571)
17. Magid R, Davies PF. Endothelial protein kinase c isoform identity and differential activity of pkczeta in an athero-susceptible region of porcine aorta. Circ Res 2005;97:443-449 (Pubitemid 41298174)
18. Zakkar M, Chaudhury H, Sandvik G, Enesa K, Luong le A, Cuhlmann S et al. Increased endothelial mitogen-Activated protein kinase phosphatase-1 expression suppresses proinflammatory activation at sites that are resistant to atherosclerosis. Circ Res 2008; 103:726-732
19. Koskinas KC, Chatzizisis YS, Antoniadis AP, Giannoglou GD. Role of endothelial shear stress in stent restenosis and thrombosis: Pathophysiologic mechanisms and implications for clinical translation. J Am Coll Cardiol 2012;59:1337-1349
20. Jimenez JM, Davies PF. Hemodynamically driven stent strut design. Ann Biomed Eng 2009; 37:1483-1494
21. Carlier SG, van Damme LC, Blommerde CP, Wentzel JJ, van Langehove G, Verheye S et al. Augmentation of wall shear stress inhibits neointimal hyperplasia after stent implantation: Inhibition through reduction of inflammation? Circulation 2003;107: 2741-2746 (Pubitemid 36667250)
22. Ueba H,Kawakami M, YaginumaT. Shear stress as an inhibitor of vascular smooth muscle cell proliferation. Role of transforming growth factor-beta 1 and tissue-Type plasminogen activator. Arterioscler Thromb Vasc Biol 1997;17:1512-1516 (Pubitemid 27387770)
23. Davies PF. Hemodynamic shear stress and the endothelium in cardiovascular pathophysiology. Nat Clin Pract Cardiovasc Med 2009;6:16-26
24. Chatzizisis YS, Coskun AU, Jonas M, Edelman ER, Feldman CL, Stone PH. Role of endothelial shear stress in the natural history of coronary atherosclerosis and vascular remodeling: Molecular, cellular, and vascular behavior. J Am Coll Cardiol 2007;49:2379-2393 (Pubitemid 46962266)
25. Timmins LH, Miller MW, Clubb FJ Jr, Moore JE Jr. Increased artery wall stress poststenting leads to greater intimal thickening. Lab Invest 2011;91:955-967
26. Haga JH, Li YS, Chien S. Molecular basis of the effects of mechanical stretch on vascular smooth muscle cells. J Biomech 2007;40:947-960 (Pubitemid 46349064)
27. Shyu KG. Cellular and molecular effects of mechanical stretch on vascular cells and cardiac myocytes. Clin Sci (Lond) 2009;116:377-389
28. Louis H, Lacolley P, Kakou A, Cattan V, Daret D, SafarMet al. Early activation of internal medial smooth muscle cells in the rabbit aorta after mechanical injury: Relationship with intimal thickening and pharmacological applications. Clin Exp Pharmacol Physiol 2006;33: 131-138
29. Tada S, Tarbell JM. Interstitial flow through the internal elastic lamina affects shear stress on arterial smooth muscle cells. Am J of Physiol Heart Circ Physiol 2000;278: H1589-H1597 (Pubitemid 30395571)
30. Shi ZD, Tarbell JM. Fluid flow mechanotransduction in vascular smooth muscle cells and fibroblasts. Ann Biomed Eng 2011;39:1608-1619
31. Yoshida T, Owens GK. Molecular determinants of vascular smooth muscle cell diversity. Circ Res 2005;96:280-291 (Pubitemid 40279902)
32. Sartore S, Franch R, Roelofs M, Chiavegato A. Molecular and cellular phenotypes and their regulation in smooth muscle. Rev Physiol Biochem Pharmacol 1999;134:235-320
33. Kawai-Kowase K, Owens GK. Multiple repressor pathways contribute to phenotypic switching of vascular smooth muscle cells. Am J Physiol Cell Physiol 2007;292:C59-C69 (Pubitemid 46127305)
34. Rensen SS, Niessen PM, van Deursen JM, Janssen BJ, Heijman E, Hermeling E et al. Smoothelin-b deficiency results in reduced arterial contractility, hypertension, and cardiac hypertrophy in mice. Circulation 2008;118:828-836
35. Benditt EP, Benditt JM. Evidence for a monoclonal origin of human atherosclerotic plaques. Proc Natl Acad Sci USA 1973;70:1753-1756
36. Murry CE, Gipaya CT, Bartosek T, Benditt EP, Schwartz SM. Monoclonality of smooth muscle cells in human atherosclerosis. Am J Pathol 1997;151:697-705
37. Coen M, Bochaton-Piallat ML. Phenotypic smooth muscle cell heterogeneity: Implications for atherosclerosis. In: George SJ, Johnson J, eds. Molecular and Cellular Mechanisms Underlying Atherosclerosis.Weinheim: Wiley-VCH; 2010. p. 327-342
38. Frid MG, Dempsey EC, Durmowicz AG, Stenmark KR. Smooth muscle cell heterogeneity in pulmonary and systemic vessels. Importance in vascular disease. Arterioscler Thromb Vasc Biol 1997;17:1203-1209 (Pubitemid 27329840)
39. Hao H, Ropraz P, Verin V, Camenzind E, Geinoz A, Pepper MS et al. Heterogeneity of smooth muscle cell populations cultured from pig coronary artery. Arterioscler Thromb Vasc Biol 2002;22:1093-1099 (Pubitemid 34764858)
40. Li S, Fan YS, Chow LH, Van Den Diepstraten C, van Der Veer E, Sims SM et al. Innate diversity of adult human arterial smooth muscle cells: Cloning of distinct subtypes from the internal thoracic artery. Circ Res 2001;89:517-525 (Pubitemid 34132646)
41. Madi HA, Riches K,Warburton P, O'Regan DJ, Turner NA, Porter KE. Inherent differences in morphology, proliferation, and migration in saphenous vein smooth muscle cells cultured from nondiabetic and type 2 diabetic patients. Am J Physiol Cell Physiol 2009;297:C1307-C1317
42. Scott NA, Cipolla GD, Ross CE, Dunn B, Martin FH, Simonet L et al. Identification of a potential role for the adventitia in vascular lesion formation after balloon overstretch injury of porcine coronary arteries. Circulation 1996;93:2178-2187 (Pubitemid 26187108)
43. Shi Y, Pieniek M, Fard A, O'Brien J, Mannion JD, Zalewski A. Adventitial remodeling after coronary arterial injury. Circulation 1996;93:340-348 (Pubitemid 26031494)
44. Christen T, Verin V, Bochaton-Piallat M, Popowski Y, Ramaekers F, Debruyne P et al. Mechanisms of neointima formation and remodeling in the porcine coronary artery. Circulation 2001;103:882-888 (Pubitemid 32163889)
45. De Leon H, Ollerenshaw JD, Griendling KK, Wilcox JN. Adventitial cells do not contribute to neointimal mass after balloon angioplasty of the rat common carotid artery. Circulation 2001;104:1591-1593 (Pubitemid 32947518)
46. Hao H, Gabbiani G, Camenzind E, Bacchetta M, Virmani R, Bochaton-Piallat ML. Phenotypic modulation of intima and media smooth muscle cells in fatal cases of coronary artery lesion. Arterioscler Thromb Vasc Biol 2006;26:326-332 (Pubitemid 43732195)
47. Tsai TN, Kirton JP, Campagnolo P, Zhang L, Xiao Q, Zhang Z et al. Contribution of stem cells to neointimal formation of decellularized vessel grafts in a novel mouse model. Am J Pathol 2012;181:362-373
48. Torsney E,HuY,XuQ. Adventitial progenitor cells contribute to arteriosclerosis. Trends Cardiovasc Med 2005;15:64-68 (Pubitemid 40693389)
49. Campagnolo P,Wong MM, Xu Q. Progenitor cells in arteriosclerosis:Good or bad guys? Antioxid Redox Signal 2011;15:1013-1027
50. Orlandi A, Bennett M. Progenitor cell-Derived smooth muscle cells in vascular disease. Biochem Pharmaco 2010;79:1706-1713
51. Brisset AC, Hao H, Camenzind E, Bacchetta M, Geinoz A, Sanchez JC et al. Intimal smooth muscle cells of porcine and human coronary artery express s100a4, a marker of the rhomboid phenotype in vitro. Circ Res 2007;100:1055-1062 (Pubitemid 46598930)
52. Greenway S, van Suylen RJ,DuMarchie Sarvaas G, KwanE, Ambartsumian N, Lukanidin E et al. S100a4/mts1 produces murine pulmonary artery changes resembling plexogenic arteriopathy and is increased in human plexogenic arteriopathy. Am J Pathol 2004;164: 253-262 (Pubitemid 38364609)
53. Marenholz I, HeizmannCW, Fritz G. S100 proteins in mouse and man: From evolution to function and pathology (including an update of the nomenclature). Biochem Biophys Res Commun 2004;322:1111-1122 (Pubitemid 39164640)
54. Sherbet GV. Metastasis promoter s100a4 is a potentially valuable molecular target for cancer therapy. Cancer Lett 2009;280:15-30
55. Mishra SK, Siddique HR, Saleem M. S100a4 calcium-binding protein is key player in tumor progression and metastasis: Preclinical and clinical evidence. Cancer Metastasis Rev 2012; 31:163-172
56. Helfman DM, Kim EJ, Lukanidin E, Grigorian M. The metastasis associated protein s100a4: Role in tumour progression and metastasis. Br J Cancer 2005;92:1955-1958 (Pubitemid 40897415)
57. Bjornland K, Winberg JO, OdegaardOT, Hovig E, Loennechen T, AasenAOet al. S100a4 involvement in metastasis: Deregulation of matrix metalloproteinases and tissue inhibitors of matrix metalloproteinases in osteosarcoma cells transfected with an anti-s100a4 ribozyme. Cancer Res 1999;59:4702-4708 (Pubitemid 29428979)
58. Mathisen B, Lindstad RI, Hansen J, El-Gewely SA, MaelandsmoGM, Hovig E et al. S100a4 regulates membrane induced activation of matrix metalloproteinase-2 in osteosarcoma cells. Clin Exp Metastasis 2003;20:701-711 (Pubitemid 38019272)
59. Lawrie A, Spiekerkoetter E, Martinez EC, Ambartsumian N, Sheward WJ, MacLean MR et al. Interdependent serotonin transporter and receptor pathways regulate s100a4/ mts1, a gene associated with pulmonary vascular disease. Circ Res 2005;97:227-235 (Pubitemid 41105448)
60. Spiekerkoetter E, Guignabert C, de Jesus Perez V, Alastalo TP, Powers JM,Wang L et al. S100a4 and bone morphogenetic protein-2 codependently induce vascular smooth muscle cell migration via phospho-extracellular signal-regulated kinase and chloride intracellular channel 4. Circ Res 2009;105:639-647
61. Frid MG, Li M, Gnanasekharan M, Burke DL, Fragoso M, Strassheim D et al. Sustained hypoxia leads to the emergence of cells with enhanced growth, migratory, and promitogenic potentials within the distal pulmonary artery wall. Am J Physiol Lung Cell Mol Physiol 2009;297:L1059-L1072
62. Giachelli CM, Speer MY, Li X, Rajachar RM, Yang H. Regulation of vascular calcification: Roles of phosphate and osteopontin. Circ Res 2005;96:717-722 (Pubitemid 40559510)
63. Haefliger JA, Nicod P, Meda P. Contribution of connexins to the function of the vascular wall. Cardiovasc Res 2004;62:345-356 (Pubitemid 38496547)
64. Chadjichristos CE,KwakBR. Connexins: Newgenes in atherosclerosis. AnnMed2007;39: 402-411
65. Chadjichristos CE, Morel S, Derouette JP, Sutter E, Roth I, BrissetACet al. Targeting connexin 43 prevents platelet-Derived growth factor-bb-induced phenotypic change in porcine coronary artery smooth muscle cells. Circ Res 2008;102:653-660 (Pubitemid 351457865)
66. Miljkovic-Licina M, Hammel P, Garrido-Urbani S, Lee BP, Meguenani M, ChaabaneCet al. Targeting olfactomedin-like 3 inhibits tumor growth by impairing angiogenesis and pericyte coverage. Mol Cancer Ther 2012;11:2588-2599
67. Cordes KR, Sheehy NT, White MP, Berry EC, Morton SU, Muth AN et al. Mir-145 and mir-143 regulate smooth muscle cell fate and plasticity. Nature 2009;460: 705-710
68. ChengY, Liu X, Yang J, LinY,XuDZ, LuQet al. Microrna-145, a novel smoothmuscle cell phenotypic marker and modulator, controls vascular neointimal lesion formation. Circ Res 2009;105:158-166
69. Elia L, Quintavalle M, Zhang J, Contu R, Cossu L, Latronico MV et al. The knockout of mir-143 and -145 alters smooth muscle cell maintenance and vascular homeostasis in mice: Correlates with human disease. Cell Death Diff 2009;16:1590-1598
70. Liu X, Cheng Y, Zhang S, Lin Y, Yang J, Zhang C. A necessary role of mir-221 and mir-222 in vascular smooth muscle cell proliferation and neointimal hyperplasia. Circ Res 2009; 104:476-487
71. Hao H, Gabbiani G, Bochaton-Piallat ML. Arterial smooth muscle cell heterogeneity: Implications for atherosclerosis and restenosis development. Arterioscler Thromb Vasc Biol 2003;23:1510-1520 (Pubitemid 37108191)
72. Berk BC. Vascular smooth muscle growth: Autocrine growth mechanisms. Physiol Rev 2001;81:999-1030 (Pubitemid 32606665)
73. Li WG, Miller FJ Jr, Brown MR, Chatterjee P, Aylsworth GR, Shao J et al. Enhanced h(2)o(2)-induced cytotoxicity in 'epithelioid' smooth muscle cells: Implications for neointimal regression. Arterioscler Thromb Vasc Biol 2000;20:1473-1479 (Pubitemid 30353876)
74. Orlandi A, Francesconi A, Cocchia D, Corsini A, Spagnoli LG. Phenotypic heterogeneity influences apoptotic susceptibility to retinoic acid and cis-platinum of rat arterial smooth muscle cells in vitro: Implications for the evolution of experimental intimal thickening. Arterioscler Thromb Vasc Biol 2001;21:1118-1123 (Pubitemid 34215138)
75. Bochaton-Piallat ML, Ropraz P, Gabbiani F, Gabbiani G. Phenotypic heterogeneity of rat arterial smooth muscle cell clones. Implications for the development of experimental intimal thickening. Arterioscler Thromb Vasc Biol 1996;16:815-820 (Pubitemid 26179371)
76. Bochaton-Piallat M-L, Gabbiani G, Pepper MS. Plasminogen activator expression in rat arterial smooth muscle cells depends on their phenotype and is modulated by cytokines. Circ Res 1998;82:1086-1093 (Pubitemid 28249069)
77. Lau HK. Regulation of proteolytic enzymes and inhibitors in two smooth muscle cell phenotypes. Cardiovasc Res 1999;43:1049-1059 (Pubitemid 29413203)
78. Adiguzel E,AhmadPJ, Franco C, BendeckMP. Collagens in the progression and complications of atherosclerosis. Vasc Med 2009;14:73-89
79. Farb A, Kolodgie FD, Hwang JY, BurkeAP, Tefera K,WeberDKet al. Extracellular matrix changes in stented human coronary arteries. Circulation 2004;110:940-947 (Pubitemid 39128619)
80. NewbyAC. Matrix metalloproteinase inhibition therapy for vascular diseases. Vasc Pharmacol 2012;56:232-244
81. Lijnen HR. Metalloproteinases in development and progression of vascular disease. Pathophysiol Haemostasis Thrombosis 2003;33:275-281 (Pubitemid 40278695)
82. Johnson JL, Dwivedi A, Somerville M, George SJ, Newby AC. Matrix metalloproteinase (mmp)-3 activates mmp-9 mediated vascular smooth muscle cell migration and neointima formation in mice. Arterioscler Thromb Vasc Biol 2011;31:e35-e44
83. Prunotto M, Bacchetta M, Jayaraman S, GalloniM, Van Eys G, GabbianiGet al. Cytostatic drugs differentially affect phenotypic features of porcine coronary artery smooth muscle cell populations. FEBS Lett 2007;581:5847-5851 (Pubitemid 50007782)
84. Luscher TF, Steffel J, Eberli FR, Joner M, NakazawaG, Tanner FC et al. Drug-eluting stent and coronary thrombosis: Biological mechanisms and clinical implications. Circulation 2007;115:1051-1058 (Pubitemid 46328299)